Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer

Biochemical and Biophysical Research Communications

Volumn 448, Issue 4, 2014, Pages 390-396

  Yoneyama, Tohru ^a   Ohyama, Chikara ^a   Hatakeyama, Shingo ^a   Narita, Shintaro ^b   Habuchi, Tomonori ^b   Koie, Takuya ^a   Mori, Kazuyuki ^a   Hidari, Kazuya I P J ^c,d   Yamaguchi, Maho ^d   Suzuki, Takashi ^d   Tobisawa, Yuki ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF AIZU   (Japan)

^d UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Cancer associated aberrant glycosylation; Immunoassay; Prostate specific antigen; 2,3 linked sialylation

Indexed keywords

N GLYCAN ON FREE PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER TEST; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LNCAP CELL LINE; MAJOR CLINICAL STUDY; MALE; MICROBEAD BASED IMMUNOASSAY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN GLYCOSYLATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

CANCER ASSOCIATED ABERRANT GLYCOSYLATION; IMMUNOASSAY; PROSTATE SPECIFIC ANTIGEN; Α2,3-LINKED SIALYLATION;

AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; EARLY DETECTION OF CANCER; GLYCOSYLATION; HUMANS; IMMUNOMAGNETIC SEPARATION; KALLIKREINS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901846756     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.04.107     Document Type: Article

References (26)

1. T.A. Stamey, N. Yang, and A.R. Hay et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N. Engl. J. Med. 317 1987 909 916
2. W.J. Catalona, D.S. Smith, and T.L. Ratliff et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N. Engl. J. Med. 324 1991 1156 1161
3. S.L. Galper, M.H. Chen, and W.J. Catalona et al. Evidence to support a continued stage migration and decrease in prostate cancer specific mortality J. Urol. 175 2006 907 912
4. F.H. Schröder, J. Hugosson, and M.J. Roobol et al. Screening and prostate-cancer mortality in a randomized European study N. Engl. J. Med. 360 2009 1320 1328
5. G.L. Andriole, E.D. Crawford, and R.L. Grubb et al. Mortality results from a randomized prostate-cancer screening trial N. Engl. J. Med. 360 2009 1310 1319
6. V.A. Moyer Screening for prostate cancer: U.S. preventive services task force recommendation statement Ann. Intern. Med. 157 2012 120 134
7. S. Payton Prostate cancer: PSA screening - more data, more debate Nat. Rev. Urol. 9 2012 59
8. S.P. Balk, Y.J. Ko, and G.J. Bubley Biology of prostate-specific antigen J. Clin. Oncol. 21 2003 383 391
9. M. Lazzeri, A. Haese, and A. de la Taille et al. Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European study Eur. Urol. 63 2013 986 994
10. S. Loeb, L.J. Sokoll, and D.L. Broyles et al. Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration J. Urol. 189 2013 1702 1706
11. S. Gilgunn, P.J. Conroy, and R. Saldova et al. Aberrant PSA glycosylation - a sweet predictor of prostate cancer Nat. Rev. Urol. 10 2013 99 107
12. T. Vermassen, M.M. Speeckaert, and N. Lumen et al. Glycosylation of prostate specific antigen and its potential diagnostic applications Clin. Chim. Acta 413 2012 1500 1505
13. M. Fukuda Possible roles of tumor-associated carbohydrate antigens Cancer Res. 56 1996 2237 2244
14. K. Yamashita, K. Taketa, and S. Nishi et al. Sugar chains of human cord serum α-fetoprotein: characteristics of N-linked sugar chains of glycoproteins in human liver and hepatocellular carcinomas Cancer Res. 53 1993 2970 2975
15. J. Amano, R. Nishimura, and M. Mochizuki et al. Comparative study of the mucin-type sugar chains of the human chorionic gonadotropin present in the urine of patients with trophoblastic diseases and healthy pregnant women J. Biol. Chem. 263 1988 1157 1165
16. A. Bélanger, H. van Halbeek, and H.C. Graves et al. Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard Prostate 27 1995 187 197
17. M. Tajiri, C. Ohyama, and Y. Wada Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach Glycobiology 18 2008 2 8
18. C. Ohyama, M. Hosono, and K. Nitta et al. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy Glycobiology 14 2004 671 679
19. B.D. Tait, F. Hudson, and L. Cantwell et al. Review article: Luminex technology for HLA antibody detection in organ transplantation Nephrology 14 2009 247 254
20. K.I. Hidari, M. Yamaguchi, and F. Ueno et al. Influenza virus utilizes N-linked sialoglycans as receptors in A549 cells Biochem. Biophys. Res. Commun. 436 2013 394 399
21. L.N. Sobin, M.K. Gospodarowicz, and C.H. Wittekind TNM Classification of Malignant Tumours Seventh ed. 2009 Wiley-Blackwell Hoboken, NJ, USA pp. 1-336
22. A. Sarrats, R. Saldova, and J. Comet et al. Glycan characterization of PSA 2-DE subforms from serum and seminal plasma, OMICS J. Integr. Biol. 14 2010 465 474
23. A. Sarrats, J. Comet, and s.G. Tabarà Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis Prostate 70 2010 1 9
24. A. Christensson, T. Björk, and O. Nilsson et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer J. Urol. 150 1993 100 105
25. Y. Seto, T. Iba, and K. Abe Development of ultra-high sensitivity bioluminescent enzyme immunoassay for prostate-specific antigen (PSA) using firefly luciferase Luminescence 16 2001 285 290
26. E.S. Meibodi, M.D. Azizi, and M. Paknejad et al. Development of an enhanced chemiluminescence immunoassay (CLIA) for detecting urinary albumin Mol. Biol. Rep. 39 2012 10851 10858